Canada markets open in 9 hours 2 minutes

ProMIS Neurosciences, Inc. (ARFXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1539-0.0054 (-3.42%)
At close: 3:28PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.1593
Open0.1546
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1539 - 0.1595
52 Week Range0.0500 - 0.2300
Volume29,367
Avg. Volume214,095
Market Cap54.465M
Beta (5Y Monthly)0.91
PE Ratio (TTM)N/A
EPS (TTM)-0.0320
Earnings DateMay 14, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ProMIS Neurosciences to Present at 2021 Alzheimer’s Association International Conference
    GlobeNewswire

    ProMIS Neurosciences to Present at 2021 Alzheimer’s Association International Conference

    Abstracts selected for oral and poster presentationsTORONTO and CAMBRIDGE, Mass., July 22, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, will give two presentations at the annual Alzheimer’s Association International Conference (AAIC®) to be held July 26-30, 2021 in Denver, USA and online.

  • Baystreet

    Stocks in play: ProMIS Neurosciences, Inc.

    Has filed, and obtained a receipt for, a final short form base shelf prospectus with the securities ...

  • ProMIS Neurosciences Obtains Receipt for Final Base Shelf Prospectus
    GlobeNewswire

    ProMIS Neurosciences Obtains Receipt for Final Base Shelf Prospectus

    NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO and CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF) (the “Company”), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, is pleas